Traditional market access practices are being transformed by an increasingly rocky landscape of rebate, discount, and direct-distribution practices, but artificial intelligence may clear the pathways to profitability.

The Key to Connecting with Patients: Pharma's Market Access Transformation

How pharma can productively coexist with PBMs—and still lower drug costs faster.

Working with the Middle

As safety data grows in scale and complexity, AI-powered pharmacovigilance is emerging as a strategic imperative—helping drugmakers improve detection, reduce risk, and strengthen commercial performance.

The Next Era of Drug Safety is in Intelligent Action

Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - December 2025

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

The acquisition expands ORBIS’ manufacturing capacity and technical expertise in reusable plastic pallets, lids, and trays, enabling faster design, prototyping, and production for pharma and broader supply chain applications.

ORBIS Acquires Robinson Industries to Boost Reusable Packaging and Thermoforming Capabilities

Videos

In the third part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains why independent verification, validation, and human decision-making must stay central, as AI accelerates data processing and operational workflows across pharma supply chains.

Human Oversight Remains Essential, as AI Expands in Pharma Manufacturing and Distribution

Podcasts

In today’s Pharma Pulse, the FDA launches its "PreCheck" pilot to speed up domestic factory approvals, while new SELECT trial data shows that semaglutide significantly slashes hospital admission rates.

Pharma Pulse: Onshoring the Supply Chain

The deal strengthens Körber’s SAP supply chain and digital manufacturing consulting portfolio, extends its global footprint, and creates Körber Stellium to deliver end-to-end supply chain and software solutions.

Körber Purchases Majority Stake in Stellium to Grow Global SAP Supply Chain Consulting Services

In the second part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, notes that in order to reduce risk and accelerate adoption, supply chain leaders can begin applying AI to machine-generated data—such as IoT sensor outputs—where insights improve performance without raising concerns about data ownership, security, or competitive exposure.

Building Trust in AI Supply Chains 

In today’s Pharma Pulse, a new national survey exposes the depth of America’s prescription access crisis, while AstraZeneca and Eli Lilly commit billions of dollars to next-generation weight-loss therapies and domestic manufacturing.

Pharma Pulse: The Access Gap

This guide breaks down how AFPs function and why they are fundamentally changing the path between patients and their therapies.

FAQ: Decoding Alternative Funding Programs

In the first part of his Pharma Commerce video interview, Joe Hudicka, entrepreneur and supply chain expert, explains how pharma leaders can detect early warning signs beyond their own silos and adapt before disruption becomes unavoidable.

The Silent Shift in Pharma Supply Chains

In today’s Pharma Pulse, HHS issues guidance for manufacturer-direct drug discounts, while clinical data warns of significant weight regain after stopping tirzepatide and semaglutide.

Pharma Pulse: HHS Bypasses PBMs and the Reality of GLP-1 Weight Regain

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, naming 15 new negotiation targets and signaling continued efforts to rein in prescription drug spending.

Featured Content

The Key to Connecting with Patients: Pharma's Market Access Transformation

Working with the Middle

The Next Era of Drug Safety is in Intelligent Action

Pharmaceutical Commerce - December 2025